Date
May 19-20, 2025 | 08:30 AM GMT
Location
Dubai, UAE
Dubai, UAE
Physician Scientist
Wellcome Trust Sanger Institute,
UK
Philip is a physician scientist with a focus on precision medicine in the field of oncology drug development and patient stratification. He followed his initial training as a haematologist with 8 years’ research in Cambridge and Vancouver, focused on understanding genotype-phenotype correlations in haematological cancers and developing improved preclinical models of leukaemia. Since then, Philip has worked cross-sector in academic, healthcare and biotech roles with a unified goal of accelerating oncology drug development and ensuring that each patient receives the most suitable therapy.
Philip’s research interests include the use of cancer genomic analysis to better understand disease behaviour and response to therapy, and the development of advanced preclinical cancer models based on human cells. Philip currently holds honorary research positions at the Wellcome Trust Sanger Institute, UK, and the Mayo Clinic, Mn, USA.
A great opportunity to network with your peers from academia and industry:
Singapore City, Singapore - Mar 17, 2025
Abstracts enquiry
Finance enquiry
Contact Enquiry
Sponsors / Advertising
Meetings International Pte Ltd, 28 Maxwell Road, 03-05 Red Dot Traffic, Singapore, 069120.
